L.1992bComparison of the aflatoxin B1-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat.1882597603 11
For context, existing FDA-approved medications for alcohol use disorder, like naltrexone and acamprosate, typically show reductions in the range of 15 to 25%
B., Seiwerth, S., Kolenc, D., Brcic, L., Aralica, G., Vuletic, M.,
Who is (and is not) a candidate for PT-141
The absence of published half-life data is a direct consequence of how early this compound is in development: it has been used as a research tool to validate an enzyme target, not as a clinical candidate with a full pharmacokinetic package
physical limitations score, quality of life score, symptom burden score, symptom frequency score and social limitations score), with estimated treatment differences ranging from 6.7 to 9.6 points